Advances in etiology, pathophysiology, diagnosis, and management of lymphedema: a comprehensive review.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing lymphedema pathophysiology, diagnosis, and treatment without systematic review methodology or original human trial data.
PubMed 41282012 · doi:10.3389/fmed.2025.1666522
What was done
This narrative review synthesized literature on the etiology, pathophysiology, diagnostic imaging tools (including lymphoscintigraphy, indocyanine green lymphography, and magnetic resonance lymphangiography), conservative management (complete decongestive therapy), microsurgery (lymphaticovenous anastomosis and vascularized lymph node transfer), and emerging pharmacologic therapies for primary and secondary lymphedema.
What was found
The abstract reports no quantitative data or specific numerical outcomes. It qualitatively describes how lymphatic stasis promotes inflammation, fibrosis, and hypoxia, outlines advancements in imaging for earlier detection, notes that complete decongestive therapy remains standard care, and describes microsurgical and targeted anti-fibrotic/anti-inflammatory treatments as evolving modalities.
Why it matters
It provides a consolidated overview of current diagnostic and therapeutic strategies for lymphedema, spanning conservative, surgical, and molecular approaches.
Limits
The paper is a broad narrative review rather than a systematic review or meta-analysis. The abstract reports no search criteria, study selection parameters, sample sizes, or quantitative outcome measures comparing the efficacy or safety of the discussed treatments.